[1]
E. LANEZ, “Theoretical Investigation of Mitomycin Derivatives as Dual Inhibitors of HER2 and ER-α: Prospects for Novel Breast Cancer Treatment Strategies”, Alger. j. biosciences, vol. 6, no. 01, Jan. 2026.